AI alerts have played and continue to play a critical role in detecting and controlling future outbreaks like COVID-19. Did you know that artificial intelligence (AI) technology first sounded the alarm on COVID-19? An algorithm developed by BlueDot, a Canadian AI firm, scoured news reports and airline ticketing data to detect the outbreak on Dec. 31, 2019 in China. On the same day, HealthMap, a Boston Children's Hospital website using AI, spotted a news report of a new type of pneumonia in Wuhan, China, and alerted global health officials. HealthMap was also the first to notify Chinese health officials that COVID-19 was expanding outside of China.

Radiology Experts Warn that Ensuring Autonomous AI Safety and Effectiveness is "A Long Way Off" Imaging artificial intelligence (AI) solutions that provide decision support or administrative assistance to radiologists are poised to improve patient care. However, regulators are currently unable to ensure safety and effectiveness of AI intended to automate key components of imaging workflow without physician-expert oversight. That is the message that the American College of Radiology (ACR) and Radiological Society of North America (RSNA) sent to the U.S. Food and Drug Administration (FDA) regarding the agency's February 2020 public workshop on the "Evolving Role of Artificial Intelligence in Radiological Imaging," which focused on higher risk, "autonomously" functioning AI. Examples of autonomous imaging AI would include algorithms that identify normal radiological examinations or rule out critical diseases. "It is unlikely FDA could provide reasonable assurance of the safety and effectiveness of autonomous AI in radiology patient care without more rigorous testing, surveillance, and other oversight mechanisms throughout the total product life cycle," the joint letter states.

Mumbai-based startup Qure uses an AI imaging tool qER to save precious minutes for emergency room staff to take action based on head CT scans. After deployment in India and several other countries, qER is now entering the US where 75 million CT scans are performed every year. A couple of weeks ago, Qure received US FDA 510 (k) clearance for this product. What makes it special is a four-in-one clearance. The tool has been cleared for triaging four critical conditions--intracranial bleeds, mass effect (due to spaces in the brain filling up), midline shift (in the brain's alignment), and cranial fractures.

A projected timeline for treatment and prevention of the novel coronavirus. Although we are living ... [ ] through uncertain times, we are also witnessing one of the greatest moments in science history. Scientists are breaking speed records in their race to develop treatments for the new coronavirus. Some are panning through old molecules hoping to find effective drugs. Others are applying the latest breakthroughs in synthetic biology to engineer sophisticated treatments and vaccines.

This opinion piece is inspired by the old Danish proverb: "Making predictions is hard, especially about the future" (1). As every reader knows, the momentum of artificial intelligence (AI) and the eventual implementation of deep learning models seem assured. Some pundits have gone considerably further, however, and predicted a sweeping AI takeover of radiology. Although many radiologists support AI and believe it will enable greater efficiency, a recent study of medical students found very different reactions (2). While such doomsday predictions are understandably attention-grabbing, they are highly unlikely, at least in the short term.

In 1906, in response to shocking reports about the disgusting conditions in U.S. meat-packing facilities, Congress created the Food and Drug Administration (FDA) to ensure safe and sanitary food production. In 1934, in the wake of the worst stock market crash in U.S. history, Congress created the Securities and Exchange Commission (SEC) to regulate capital markets. In 1970, as the nation became increasingly alarmed about the deterioration of the natural environment, Congress created the Environmental Protection Agency (EPA) to ensure cleaner skies and waters. When an entire field begins to create a broad set of challenges for the public, demanding thoughtful regulation, a proven governmental approach is to create a federal agency focused specifically on engaging with and managing that field. The time has come to create a federal agency for artificial intelligence.

When it comes to Covid-19, one big question is how are we using artificial intelligence (AI) to help? While there is much focus on contact tracing and virus research, there are other big problems resulting from the coronavirus. Going beyond this, there are five key ares for people to focus AI on.

The U.S. Congress should create a federal agency for artificial intelligence. In 1906, in response to shocking reports about the disgusting conditions in U.S. meat-packing facilities, Congress created the Food and Drug Administration (FDA) to ensure safe and sanitary food production. In 1934, in the wake of the worst stock market crash in U.S. history, Congress created the Securities and Exchange Commission (SEC) to regulate capital markets. In 1970, as the nation became increasingly alarmed about the deterioration of the natural environment, Congress created the Environmental Protection Agency (EPA) to ensure cleaner skies and waters. When an entire field begins to create a broad set of challenges for the public, demanding thoughtful regulation, a proven governmental approach is to create a federal agency focused specifically on engaging with and managing that field.

AI/ ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective. FDA has regulated medical software by means of regulation and guidance's for years, however, AI/ML programs fall outside the scope of these regulations and guidance's. This happens because FDA approves the final, validated version of the software. The point of AI/ML is to learn and update following deployment to improve performance. Thus the field version of the software is no longer the validated approved version.

As a way to see inside the body, revealing a tumor or a fetus, ultrasound is tried and true. But neuroscientists have a newer ambition for the technology: tinkering with the brain. At frequencies lower than those of a sonogram but still beyond the range of human hearing, ultrasound can penetrate the skull and boost or suppress brain activity. If researchers can prove that ultrasound safely and predictably changes human brain function, it could become a powerful, noninvasive research tool and a new means of treating brain disorders. How ultrasound works on the brain remains mysterious. But recent experiments have offered reassurance about safety, and small studies hint at meaningful effects in humans—dampening pain, for example, or subtly enhancing perception. “I've seen a lot of tantalizing data,” says Mark Cohen, a neuroscientist at the University of California, Los Angeles (UCLA). “While the challenges are very large, the potential of this thing is so much larger that we really have to pursue it.” Scientists can already modulate the brain noninvasively by delivering electric current or magnetic pulses across the skull. The U.S. Food and Drug Administration (FDA) has approved transcranial magnetic stimulation (TMS) to treat depression, migraine pain, and obsessive-compulsive disorder (OCD). But unlike magnetic or electric fields, sound waves can be focused—like light through a magnifying glass—on a point deep in the brain without affecting shallower tissue. For now, that combination of depth and focus is possible only with a surgically implanted wire. But ultrasound could temporarily disrupt a deep human brain region—the almond-shaped amygdala, a driver of emotional responses, for example, or the thalamus, a relay station for pain and regulator of alertness—to test its function or treat disease. Results in animals are encouraging. Experiments in the 1950s first showed ultrasound waves could suppress neural activity in a visual region of the cat brain. In rodents, aiming ultrasound at motor regions has triggered movements such as a twitch of a paw or whisker. And focusing it on a frontal region of monkey brains can change how the animals perform at eye movement tasks. But it's technically tricky to aim ultrasound through thick, dense skull bone and to show its energy has landed at the intended point. And ultrasound's effects on the brain can be hard to predict. How much it boosts or suppresses neural activity depends on many parameters, including the timing and intensity of ultrasound pulses, and even characteristics of the targeted neurons themselves. “I have tremendous excitement about the potential,” says Sarah Hollingsworth Lisanby, a psychiatrist at the National Institute of Mental Health who studies noninvasive neuromodulation. “We also need to acknowledge that there's a lot we have to learn,” she says. For one thing, researchers are largely in the dark about how sound waves and brain cells interact. “That's the million-dollar question in this field,” says Mikhail Shapiro, a biochemical engineer at the California Institute of Technology. At high intensities, ultrasound can heat up and kill brain cells—a feature neurosurgeons have exploited to burn away sections of brain responsible for tremors. Even at intensities that don't significantly increase temperature, ultrasound exerts a mechanical force on cells. Some studies suggest this force alters ion channels on neurons, changing the cells' likelihood of firing a signal to neighbors. If ultrasound works primarily via ion channels, “That's great news,” Shapiro says, “because that means we can look at where those channels are expressed and make some predictions about what cell types will be excited.” In a preprint on bioRxiv last month, Shapiro's team reported that exposing mouse neurons in a dish to ultrasound opens a particular set of calcium ion channels to render certain cells more excitable. But these channels alone won't explain ultrasound's effects, says Seung-Schik Yoo, a neuroscientist at Harvard University. He notes that ultrasound also appears to affect receptors on nonneuronal brain cells called glia. “It's very hard to [develop] any unifying theory about the exact mechanism” of ultrasound, he says. Regardless of mechanism, ultrasound is starting to show clear, if subtle, effects in humans. In 2014, a team at Virginia Polytechnic Institute and State University showed focused ultrasound could increase electrical activity in a sensory processing region of the human brain and improve participants' ability to discern the number of points being touched on their fingers. Neurologist Christopher Butler at the University of Oxford and colleagues have tested ultrasound during a more complex sensory task: judging the motion of drifting, jiggling dots on a screen. Last month at the Cognitive Neuroscience Society's annual meeting online, he reported that stimulating a motion-processing visual region called MT improved subjects' ability to judge which way the majority of the dots drifted. Ultrasound's effects have so far been subtler than those of TMS, says Mark George, a psychiatrist at the Medical University of South Carolina, who helped develop and refine that technology. With TMS, “you put it on your head and turn it on and your thumb moves,” he says. But the ultrasound experiments that prompted paw twitches in mice used intensities “so, so, so much higher than what we're being allowed to use in humans.” Regulators have limited human studies in part because ultrasound has the potential to cook the brain or cause damage through cavitation—the creation of tiny bubbles in tissue. In 2015, Yoo and colleagues found microbleeds, a sign of blood vessel damage, in sheep brains repeatedly exposed to ultrasound. “This was a huge speed bump,” says Kim Butts Pauly, a biophysicist at Stanford University. But in February in Brain Stimulation , her group reported microbleeds in control animals as well, suggesting this damage might result from dissection of the brains. Butts Pauly and Yoo now say they're confident the technology can be used safely. Cohen and collaborators recently tested safety in people by aiming ultrasound at regions slated for surgical removal to treat epilepsy. With FDA's OK, they used intensities up to eight times as high as the limit for diagnostic ultrasound. As they reported in a preprint on medRxiv in April, they found no significant damage to brain tissue or blood vessels. However, to find the limit of safety, researchers will likely need to go all the way to levels that damage tissue, Cohen says. Several teams are cautiously moving into tests of ultrasound as treatment. In 2016, UCLA neuroscientist Martin Monti and colleagues reported that a man in a minimally conscious state regained consciousness following ultrasound stimulation of his thalamus. Monti is preparing a publication on a follow-up study of three people with chronically impaired states of consciousness. After ultrasound, they showed increased responsiveness over a period of days—much faster than expected, Monti says, although the study included no control group. That research and the tests in epilepsy patients used an ultrasound device developed by BrainSonix Corporation. Its founder, UCLA neuropsychiatrist Alexander Bystritsky, hopes ultrasound can disrupt neural circuits that drive symptoms of OCD. A team at Massachusetts General Hospital and Baylor College of Medicine is planning a study in humans using the BrainSonix device, he says. Columbia University biomedical engineer Elisa Konofagou hopes to use ultrasound to treat Alzheimer's disease. Before COVID-19 interrupted participant recruitment, she and colleagues were preparing a pilot study to inject tiny gas-filled bubbles into the bloodstream of six people with Alzheimer's and use pulses of ultrasound to oscillate the microbubbles in blood vessels lining the brain. The mechanical force of those vibrations can temporarily pull apart the cells lining these vessels. The researchers hope opening this blood-brain barrier will help the brain clear toxic proteins. (Konofagou's team and others are also exploring this ultrasound-microbubble combination to deliver drugs to the brain.) In his first test of ultrasound after years of studying TMS, George looked to reduce pain. His team applied increasing heat to the arms of 19 participants, who tended to become more sensitive over repeated tests, reporting pain at lower temperatures by the last test. But if, between the first and last test, they had pulses of ultrasound aimed at the thalamus, their pain threshold dipped half as much. “This is definitely a double green light” to keep pursuing the technology, George says. George regularly treats depressed patients with TMS and has seen the technology save lives. “But everybody wonders if we could go deep with a different technology—that would be a game changer,” he says. “Ultrasound holds that promise, but the question is can it really deliver?”